Will Canopy Growth (TSX:WEED) Stock Rebound in 2020?

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) stock could rebound stronger than before in 2020.

| More on:

The first full year of legalization was surprisingly rough for marijuana stocks across the board. The industry has collectively lost $21 billion (or roughly a third) of its combined market capitalization in 2019 alone. High-profile executives like Cam Battley and Bruce Linton lost their jobs while high-profile institutional investors were humbled by their performance in this sector. 

However, this is a new year and there are signs that the cannabis sector could rebound stronger than before in 2020. In particular, the fallout from last year could help industry leaders like Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) consolidate their position. 

Here are three reasons I believe Canopy’s stock could regain its peak valuation in the year ahead. 

Cash reserves

At the time of writing, Canopy has nearly $2.75 billion in cash and cash equivalents on its books. That’s plenty of money to keep production going as the distribution channels settle. 

In fact, the company can now use its cash hoard to acquire smaller players that have suffered from last year’s market shakeout. Smaller firms that have invested heavily in their production facilities and are now dealing with unsustainable debt could be acquired and consolidated by the cash-rich, low-debt market leader. 

A market consolidation will further cement Canopy’s position in this sector. 

Cannabis 2.0 launches

Investors should expect edible cannabis products to have a larger pool of buyers and command higher margins. There are a lot more people willing to ingest cannabis products rather than smoke or inhale it. It’s also easier to brand and market these items as recreational products for the average consumer. 

With 13 cannabis-infused drinks and a line of cannabis-infused chocolate as part of its Cannabis 2.0. portfolio and a joint venture with Toronto rap star Drake, Canopy is already well ahead of the rest in this market. If the products have the desired impact on the company’s margins, Canopy’s timeline for profitability could be shortened considerably.

New management

A change in the C-suite is a critical catalyst for most companies. David Klein, the chief financial officer at Canopy’s largest shareholder Constellation Brands, is expected to take over the chief executive officer role from Mark Zekulin, effective this week. 

Considering the fact that Klein is a former financial executive, investors should expect the company’s focus to shift to the bottom line going forward. A shift in strategy and a focus on financial efficiency is exactly what this company needs to unlock value.

Canopy’s stock currently trades at just 1.86 times book value and 3.27 times cash per share. Considering the immense potential for global cannabis sales and Canopy’s dominant position in the market, I expect Canopy’s stock to surge back up to reflect its capacity for growth.

Bottom line

The fallout from last year could benefit industry leaders like Canopy Growth in 2020. Profitability is the firm’s main issue at the moment, but with higher-margin products being rolled out this year and decreased competition from failed rivals, this issue could be resolved. Canopy has all the resources and market share it needs to rebound stronger than before and dominate the market in the new year.

The Motley Fool recommends Constellation Brands. Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »